Sort   by:  
 Page size 
UnknownDCIS and LCIS: Are the Risk Factors for Developing In Situ Breast Cancer Different?
Not available
S-EPMC10486708 | biostudies-literature
UnknownBreast Cancer Polygenic Risk Score Associated with Outcomes after In Situ Breast Disease.
Not available
S-EPMC12580823 | biostudies-literature
UnknownThe prevalence of cardiac autonomic neuropathy in prediabetes: a systematic review.
Not available
S-EPMC7801295 | biostudies-literature
UnknownExpert UK consensus on the definition of high risk of recurrence in HER2-negative early breast cancer: A modified Delphi panel.
Not available
S-EPMC10539921 | biostudies-literature
UnknownPIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression.
Not available
S-EPMC5240238 | biostudies-literature
UnknownFrequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years.
Not available
S-EPMC6501320 | biostudies-literature
UnknownGermline CDH1 mutations in bilateral lobular carcinoma in situ.
Not available
S-EPMC3929874 | biostudies-literature
UnknownReview of systematic reviews of non-pharmacological interventions to improve quality of life in cancer survivors.
Not available
S-EPMC5719270 | biostudies-literature
UnknownStudy protocol for a randomised controlled trial of brief, habit-based, lifestyle advice for cancer survivors: exploring behavioural outcomes for the Advancing Survivorship Cancer Outcomes Trial (ASCOT).
Not available
S-EPMC5178807 | biostudies-literature
UnknownHER-SAFE study design: an open-label, randomised controlled trial to investigate the safety of withdrawal of pharmacological treatment for recovered HER2-targeted therapy-related cardiac dysfunction.
Not available
S-EPMC11800297 | biostudies-literature
Sort   by:  
 Page size